Circuit TX develops optogenetic therapies that use light to precisely activate or inhibit nerve cells, enabling new treatment approaches for neurological diseases. By integrating optogenetics with precision medicine, the company aims to create novel therapeutic modalities and accelerate drug discovery, leveraging its industry‑leading expertise in neuroscience research.
Funding
Funding not disclosed
Founders
Product
Problem
Current treatments for neurological diseases often lack the ability to precisely control neuronal activity in time and space, limiting efficacy and leading to off‑target effects. Traditional drug discovery approaches also struggle to model the dynamic behavior of neural circuits, slowing the development of new therapies.
Solution
Circuit Therapeutics leverages optogenetic technology to deliver light‑controlled modulation of specific nerve cells, enabling therapeutic interventions with biologically relevant timing and spatial precision. Their platform provides engineered light‑sensitive proteins and delivery methods that can excite or inhibit targeted neurons in vivo. By integrating this capability into both direct therapeutic programs and drug discovery pipelines, the company creates a new modality for treating neurological disorders and a tool for uncovering disease mechanisms. The approach supports precision‑medicine strategies, allowing therapies to be tailored to the functional state of neural circuits.
Target Audience
Primary customers include pharmaceutical and biotech companies developing neurological therapeutics, as well as academic and contract research laboratories conducting neuroscience studies.
Features
- Engineered opsins and viral vectors optimized for safe, targeted expression in human neuronal populations
- Light delivery systems designed for precise, minimally invasive activation or inhibition of specific neural pathways
- Compatibility with existing preclinical models to assess functional outcomes and disease modulation
- Platform enables high‑resolution temporal control, matching the natural firing patterns of neurons
- Supports both therapeutic development and mechanistic drug discovery by providing functional readouts of neural circuit activity